Assessment of Pneumocystis species carriage in captive primates
C. DEMANCHE, T. PETIT, P. MOISSON, F. OLLIVET, J. RIGOULET, R. CHERMETTE, E, DEI-CAS, A. E. WAKEFIELD, J. GuIlLLOT Pneumocystis species are recognised as major opportunistic fungal pathogens which cause life-threatening pneumonia in severely ill or malnourished mammals, especially primates. In human beings, Pneumocystis pneumonia remains the most common initial manifestation of acquired immunodeficiency syndrome (AIDS) (Roux and others 1998) . Cancer patients and transplant recipients may also be affected. In other primate species, cases of pneumocystosis have regularly been reported in animals with naturally occurring or experimentally induced immunodeficiency syndromes. Most cases have concerned macaque species infected with either simian immunodeficiency virus (Baskerville and others 1991 , Furuta and others 1993 , Vogel and others 1993 , Yanai and others 1999 or chimaeric simian-human immunodeficiency virus (Shibata and others 1997, Durand-Joly and others 2000) . New World primates may also be affected (Long and others 1975 , Poelma 1975 , Richter and others 1978 , Kobayashi and others 1999 (Wakefield 1996) . The primer sets pAZI02-H/pAZI02-E (5'-GATGGGTGTTTCCAAGCCCA-3'/5'-GTGTACGTTGCAAAGTACTC-3') and pAZ102-X/R1/pAZ102-Y/R1 (5'-GGGAATTCGTGAAATACAAATCGGACTAGG-3'/5'-GGGAATTCT CACTTAATATTAATTGGGGAGC-3') were used. Primers pAZ102-H and pAZI02-E are routinely used for the diagnosis of pneumocystosis in human beings. Primers pAZI02-X/Rl and pAZI02-Y/Rl were initially designed for the detection of Pneumocystis species DNA in environmental samples, but they were shown to be appropriate for the detection of Pneumocystis species in lung tissue samples from non-human primates as well (Demanche and others 2001) . Negative controls were included in both the DNA extraction and PCR amplification stages to monitor for possible contamination. The PCR products were electrophoresed in 2 per cent agarose gels and visualised by ethidium bromide staining.
Fisher's exact probability tests were carried out using Epi Info 2000 software (version 1.1.2) to compare the prevalences of Pneumocystis species carriage in the simian populations. P<0-05 was considered to be significant.
Lung tissue samples were collected from 83 primates representing 26 different species; 15 New World species (63 animals) and 11 Old World species (20 animals). Forty-one of the primates were female, 34 were male and eight were too young for their sex to be determined. Twenty-five samples were collected from unweaned primates, 12 from subadult animals and 46 from sexually mature adults. Serological analyses proved that none of the Old World primates was infected by an immunosuppressive retrovirus. There was no history of the use of immunosuppressive or cytotoxic medication.
Pneumocystis cysts were observed in lung samples from seven New World primates (one squirrel monkey, two Geoffroy's marmosets, one red-handed tamarin, one Goeldi's monkey and two Weddell's tamarins). However, there was no clinical or pathological evidence of pneumocystosis in these (Ito and others 1991) but is suspected in human beings (Mortier and others 1995) and has been proved in rabbits (Cere and others 1997) . Another reservoir of Pneumocystis species could be the environment. This possibility would account for the seasonal variations in Pneumocystis carriage observed in wild rodents and insectivores in Finland (Laakkonen and others 1999 
